Advertisement AliX and Sosho sign supply agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

AliX and Sosho sign supply agreement

AliX, a contract research organization and Sosho, an Osaka University spin-off with expertise in crystallogenesis, have entered into an exclusive agreement to supply biopharmaceuticals companies with protein structure determination solutions for difficult targets.

Within the frame of the collaboration, AliX will provide Sosho with its protein engineering expertise and Sosho will apply its crystallization technology. Sosho is using femto-second laser irradiation of protein solution to induce crystal nucleation and to promote crystal growth.

Joining forces, AliX and Sosho will offer enhanced protein structure determination services to biopharmaceuticals companies. In addition, AliX and SOSHO have already started a research collaboration to determine crystal structures of intractable targets relevant to therapeutic research.

According to Jean-Paul Renaud, chief scientific officer of AliX, and Tsuyoshi Inoue, chief scientific officer of Sosho, combining the expertise of both companies will provide a unique opportunity to solve difficult problems, including membrane protein crystallization.